HIGHLIGHTS
- who: Manisha Kapdi from the NHL Municipal Medical College, Ahmedabad, Gujarat, India have published the research work: Comparative study of intrathecal preservative-free midazolam versus nalbuphine as an adjuvant to intrathecal bupivacaine (0.5%) in patients undergoing elective lower-segment caesarean section, in the Journal: (JOURNAL)
- what: The authors aim to assess nalbuphine/midazolam as adjuvant to bupivacaine for LSCS in terms of quality of sensorimotor block postoperative analgesia adverse effects hemodynamic stability and Apgar scores of baby at 1 and 5 min. This study was undertaken to evaluate and compare analgesic efficacy, hemodynamic stability . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.